Trade Setup Buy Target $1.64 Sell Target $1.82 Aytu BioScience, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel products in the field of hypogonadism (low testosterone), cough and upper respiratory symptoms, insomnia, and male infertility in the United States and internationally.
Read MoreTrade Setup Stocks found in this category are low priced stocks priced between .50 and $1, with at least 50k shares of average shares trading per day. The stocks are pausing a trend either up or down, with a new bar over the prior day open or close. These are high reward to risk stocks with the […]
Read MoreBuy Price: $4.25 or better Sell Price: TradersPro Sell Signal Agenus Inc., a clinical-stage immuno-oncology company, engages in advancing a pipeline of immune checkpoint antibodies, adoptive cell therapies and neoantigen cancer vaccines, to fight cancer. The company offers Retrocyte Display, an antibody discovery platform for the identification of fully-human and humanized monoclonal antibodies; and display […]
Read MorePlus, Gilead is gearing up to test an inhaled version of its antiviral drug remdesivir in the treatment of COVID-19, Microsoft is acquiring a cybersecurity startup, and Wirecard shares tanked after it said the $2.1 billion missing from its balance sheet likely doesn’t exist.
Read MoreThe U.S. economy could be starting to find its footing again. While unemployment as a total number remains high, it does appear to be flattening nationally, and has even starting to drop in a number of states. COVID-19 isn’t going away – in fact, if the weekend’s reports are accurate, I think that we are […]
Read More